Condition

Clinical Trials for Lymphangioleiomyomatosis

Active Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 15
  • Start Date: June 30, 2020
Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 5
  • Start Date: October 18, 2019
Glutamine PET Imaging in LAM
Search for trials
Clinical Trial
  • Status: Recruiting
  • Participants: 1000
  • Start Date: August 1, 2018
Biomarkers for Tuberous Sclerosis Complex: An International Multicenter Observational Longitudinal Protocol
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: January 1, 2018
Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
Clinical Trial
  • Status: Recruiting
  • Participants: 26
  • Start Date: December 4, 2017
Discovery of Sirolimus Sensitive Biomarkers in Blood
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: October 2016
A Pilot Study of Nintedanib for LymphAngioleioMyomatosis (LAM)
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Drug
  • Participants: 600
  • Start Date: March 2015
Multicenter International Durability and Safety of Sirolimus in LAM Trial (MIDAS)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Procedure, Drug
  • Participants: 100
  • Start Date: June 10, 2013
13-H-0051 Bronchodilator Effects of Nebulized Versus Inhaled Albuterol in Subjects With Lymphangioleiomyomatosis
Clinical Trial
  • Status: Recruiting
  • Participants: 1000
  • Start Date: June 2013
Lymphatic Anomalies Registry for the Assessment of Outcome Data
Showing 1-12 of 15